Cellectis SA 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
CLLS
Cellectis SACellectis S.A. files an amendment to its 20-F annual report to correct administrative errors in the consents provided by KPMG SA and Ernst & Young et Autres.
NASDAQ
CLLS
Cellectis SACellectis S.A. releases its annual report, detailing financial results, strategic plans, and risk factors for the fiscal year ended December 31, 2024.
NASDAQ
CLLS
Cellectis SACellectis enters into a subscription agreement with the European Investment Bank (EIB) for the issuance of warrants, linked to tranches of a finance contract.